Thomas Kuntz, Julian Siebdrath, Silke C Hofmann, Mehmet Baltaci, Jörg Schaller, Martin Hellmich, Luise Stach von Goltzheim, Chalid Assaf, Frank Oellig, Alena-Lioba Michalowitz, Doris Helbig, Alexander Kreuter
BACKGROUND AND OBJECTIVES: In recent years, considerable insight has been gained into the pathogenesis, diagnosis and treatment of cutaneous sarcomas, including atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS). Both entities have shown increasing incidence rates in the last decade. This study was initiated to evaluate how these new insights impact the number of diagnoses of AFX/PDS compared to other cutaneous sarcoma entities. PATIENTS AND METHODS: In a retrospective study of four German skin cancer centers, all histopathological reports of cutaneous sarcomas (AFX, PDS, dermatofibrosarcoma protuberans, cutaneous leiomyosarcoma, angiosarcoma, and Kaposi sarcoma) confirmed by board-certified dermatopathologists were analyzed during a time-period of seven years (2013-2019)...
November 28, 2022: Journal der Deutschen Dermatologischen Gesellschaft: JDDG